|
1
|
Jahng Y: Progress in the studies on
tryptanthrin, an alkaloid of history. Arch Pharm Res. 36:517–535.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wagner-Döbler I, Rheims H, Felske A,
El-Ghezal A, Flade-Schröder D, Laatsch H, Lang S, Pukall R and
Tindall BJ: Oceanibulbus indolifex gen. nov., sp. nov., a North Sea
alphap-roteobacterium that produces bioactive metabolites. Int J
System Evol Microbial. 54:1177–1184. 2004. View Article : Google Scholar
|
|
3
|
Vlachos C, Schulte BM, Magiatis P, Adema
GJ and Gaitanis G: Malassezia-derived indoles activate the aryl
hydrocarbon receptor and inhibit Toll-like receptor-induced
maturation in mono-cyte-derived dendritic cells. Br J Dermatol.
167:496–505. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cheng HM, Wu YC, Wang Q, Song M, Wu J,
Chen D, Li K, Wadman E, Kao ST, Li TC, et al: Clinical efficacy and
IL-17 targeting mechanism of Indigo naturalis as a topical agent in
moderate psoriasis. BMC Complement Altern Med. 17:4392017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kaur R, Manjal SK, Rawal RK and Kumar K:
Recent synthetic and medicinal perspectives of tryptanthrin. Bioorg
Med Chem. 25:4533–4552. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mitcher LA and Baker W: Tuberculosis: A
search for novel therapy starting with natural products. Med Res
Revs. 18:363–374. 1998. View Article : Google Scholar
|
|
7
|
Krivogorsky B, Grundt P, Yolken R and
Jones-Brando L: Inhibition of Toxoplasma gondii by indirubin and
tryptanthrin analogs. Antimicrob Agents Chemother. 52:4466–4469.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mitscher LA, Wong WC, De Meulenaere T,
Sulko J and Drake S: Antimicrobial agents from plants. New
synthesis and bioactivity of tryptanthrin
(indolo[2,1-b]quinazoline-6,12-dione) and its derivatives.
Heterocycles. 15:1017–1021. 1981. View Article : Google Scholar
|
|
9
|
Popov AM, Gafurov YM, Moskovkina TV,
Kachanov AV, Krivoshapko ON, Petrovicheva SE and Stonik VA:
Kourokhitin, a potential drug containing two active substances.
Dokl Biochem Biophys. 426:131–133. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Popov AM, Nedashkovskaya OI, Gafurov YM
and Moskovkina TV: Antimicrobial activity of «Kourochitin»
preparation. Russ J Biopharm. 3:19–22. 2011.
|
|
11
|
Popov AM, Shtoda YP, Krivoshapko ON,
Gafurov YM and Moskovkina TV: Wound healing activity of different
ointment forms of quinazoline alkaloid tryptanthrin. Russ J
Biopharm. 4:21–24. 2012.
|
|
12
|
Popov AM, Krivoshapko ON, Tsybulsky AV,
Shtoda YP, Klimovich AA, Gafurov YM and Artyukov AA: Therapeutic
activity of preparation «Kourochitin» at modeling allergic
dermatitis. Russ J Biopharm. 7:24–30. 2015.
|
|
13
|
Popov AM, Osipov AN, Korepanova EA,
Krivoshapko ON, Shtoda YP and Klimovich AA: Study of antioxidant
and membranotropic activities of quinazoline alkaloid tryptanthrin
using different model systems. Biofizika. 60:700–707. 2015.In
Russian. PubMed/NCBI
|
|
14
|
Klimovich AA, Popov AM, Krivoshapko ON,
Shtoda YP and Tsybulsky AV: A comparative assessment of the effects
of alkaloid tryptanthrin, rosmarinic acid, and doxorubicin on the
redox status of tumour and immune cells. Biophysics. 62:588–594.
2017. View Article : Google Scholar
|
|
15
|
Moskovkina TV, Denisenko VA, Kalinovskii
AI and Stonik VA: Synthesis of substituted tryptanthrins via
oxidation of isatin and its derivatives. Russ J Org Chem.
49:1740–1743. 2013. View Article : Google Scholar
|
|
16
|
Moskovkina TV, Kalinovskii AI and
Makhan'kov VV: Synthesis of tryptanthrin (couroupitine) derivatives
by reaction of substituted isatins with phosphoryl chloride. Rus J
Org Chem. 48:123–126. 2012. View Article : Google Scholar
|
|
17
|
Bruker: APEX2. Bruker AXS Inc; Madison,
WI: 2012
|
|
18
|
Sheldrick GM: SHELXT-integrated
space-group and crystal-structure determination. Acta Crystallogr A
Found Adv. 71:3–8. 2015. View Article : Google Scholar :
|
|
19
|
Tikhomirov AS, Tsvetkov VB, Kaluzhny DN,
Volodina YL, Zatonsky GV, Schols D and Shchekotikhin AE: Tri-armed
ligands of G-quadruplex on heteroarenefused anthraquinone
scaffolds: Design, synthesis and pre-screening of biological
properties. Eur J Med Chem. 159:59–73. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
McGhee JD and von Hippel PH: Theoretical
aspects of DNA-protein interactions: Co-operative and
non-co-operative binding of large ligands to a one-dimensional
homogeneous lattice. J Mol Biol. 86:469–489. 1974. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Akhila JS, Deepa S and Alwar MC: Acute
toxicity studies and median lethal dose. Curr Sci. 93:917–920.
2007.
|
|
22
|
Elsherbinya NM, Younisb NN, Shaheenc MA
and Elseweidy MM: The synergistic effect between vanillin and
doxorubicin in Ehrlich ascites carcinoma solid tumour and MCF-7
human breast cancer cell line. Pathol Res Pract. 212:767–777. 2016.
View Article : Google Scholar
|
|
23
|
Fedeli W and Mazza F: Crystal structure of
tryptanthrin (indolo[2,1-b]quinazoline-6,12-dione. J Chem Soc
Perkin Trans. 2:1621–1623. 1974. View Article : Google Scholar
|
|
24
|
Kimoto T, Hino K, Koya-Miyata S, Yamamoto
Y, Takeuchi M, Nishizaki Y, Micallef MJ, Ushio S, Iwaki K, Ikeda M
and Kurimoto M: Cell differentiation and apoptosis of monocytic and
promyelocytic leukemia cells (U-937 and HL-60) by tryptanthrin, an
active ingredient of Polygonum tinctorium Lour. Pathol Int.
51:315–325. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yu ST, Chern JW, Chen TM, Chiu YF, Chen HT
and Chen YH: Cytotoxicity and reversal of multidrug resistance by
trypt-anthrin-derived indoloquinazolines. Acta Pharmacol Sin.
31:259–264. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jao CW, Lin WC, Wu YT and Wu PL:
Isolation, structure eluci-dation, and synthesis of cytotoxic
tryptanthrin analogues from Phaius mishmensis. J Nat Prod.
71:1275–1279. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Duncan M, DeLuca T, Kuo HY, Yi M, Mrksich
M and Miller WM: SIRT1 is a critical regulator of K562 cell growth,
survival, and differentiation. Exp Cell Res. 344:40–52. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Deo KM, Pages BJ, Ang DL, Gordon CP and
Aldrich-Wright JR: Transition metal intercalators as anticancer
agents-recent advances. Int J Mol Sci. 17:18182016. View Article : Google Scholar
|
|
29
|
Ito W, Takeda M, Ueki S, Tanigai T, Kayaba
H and Chihara J: Effect of the hepatocyte growth factor on allergic
inflammatory cells. Int Arch Allergy Immunol. 152(Suppl 1):
S96–S100. 2010. View Article : Google Scholar
|
|
30
|
Honda G, Tabata M and Tsuda M: The
antimicrobial specificity of tryptanthrin. Planta Med. 37:172–174.
1979. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bandekar PP, Roopnarine KA, Parekh VJ,
Mitchell TR, Novak MJ and Sinden RR: Antimicrobial activity of
tryptanthrins in Escherichia coli. J Med Chem. 53:3558–3565. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kataoka M, Hirata K, Kunikata T, Ushio S,
Iwaki K, Ohashi K, Ikeda M and Kurimoto M: Antibacterial action of
tryptanthrin and kaempferol, isolated from the indigo plant
(Polygonum tinctorium Lour.), against Helicobacter pylori-infected
Mongolian gerbils. J Gastroenterol. 36:5–9. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kawakami J, Matsushima N, Ogawa Y,
Kakinami H, Nakane A, Kitahara H, Nagaki M and Ito S: Antibacterial
and antifungal activities of tryptanthrin derivatives. Trans Mat
Res Soc Japan. 36:603–606. 2011. View Article : Google Scholar
|
|
34
|
Hwang JM, Oh T, Kaneko T, Upton AM,
Franzblau SG, Ma Z, Cho SN and Kim P: Design, synthesis, and
structure-activity relationship studies of tryptanthrins as
antitubercular agents. J Nat Prod. 76:354–367. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Scovill J, Blank E, Konnick M, Nenortas E
and Shapiro T: Antitrypanosomal activities of Tryptanthrins.
Antimicrob Agents Chemother. 46:882–883. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kamal A, Reddy BV, Sridevi B, Ravikumar A,
Venkateswarlu A, Sravanthi G, Sridevi JP, Yogeeswari P and Sriram
D: Synthesis and biological evaluation of phaitanthrin congeners as
anti-myco-bacterial agents. Bioorg Med Chem Lett. 25:3867–3872.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chollet A, Maveyraud L, Lherbet C and
Bernardes-Génisson V: An overview on crystal structures of InhA
protein: Apo-form, in complex with its natural ligands and
inhibitors. Eur J Med Chem. 146:318–343. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sugiura K: Relative sensitivity of the
solid and ascites forms of sarcoma 180 and Ehrlich carcinoma to
inhibitory compounds. Ann N Y Acad Sci. 76:575–585. 1958.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ishihara T, Kohno K, Ushio S, Iwaki K,
Ikeda M and Kurimoto M: Tryptanthrin inhibits nitric oxide and
prostaglandin E(2) synthesis by murine macrophages. EurJ Pharmacol.
407:197–204. 2000. View Article : Google Scholar
|
|
40
|
Pergola C, Jazzar B, Rossi A, Northoff H,
Hamburger M, Sautebin L and Werz O: On the inhibition of
5-lipoxygenase product formation by tryptanthrin: Mechanistic
studies and efficacy in vivo. Br J Pharmacol. 165:765–776. 2012.
View Article : Google Scholar :
|
|
41
|
Han NR, Kim HM and Jeong HJ: Thymic
stromal lymphopoietin is regulated by the intracellular calcium.
Cytokine. 59:215–217. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hernandez-Santana YE, Giannoudaki E, Leon
G, Lucitt MB and Walsh PT: Current perspectives on the
interleukin-1 family as targets for inflammatory disease. Eur J
Immunol. 49:1306–1320. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Pathania AS, Kumar S, Guru SK, Bhushan S,
Sharma PR, Aithagani SK, Singh PP, Vishwakarma RA, Kumar A and
Malik F: The synthetic tryptanthrin analogue suppresses STAT3
signaling and induces caspase dependent apoptosis via ERK Up
regulation in human leukemia HL-60 cells. PLoS One. 9:e1104112014.
View Article : Google Scholar : PubMed/NCBI
|
